MoneyWorks4Me

Bafna Pharmaceuticals informs about disclosure

09 Mar 2022 Evaluate
Bafna Pharmaceuticals has informed that it enclosed proposed sale of equity shares of Bafna Pharmaceuticals by SRJR Life Science LLP, through open market sale for achieving minimum public shareholding.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..